13F-HR filed by Healthcare Value Capital, LLC
Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 26 holding rows worth $54,708,000.
- Accession
- 0000919574-15-001370
- Filer
- CIK 1458461
- Filed
- 2015-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 26 entries on the cover page, a total value of $54,708,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $54,712,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALBANY MOLECULAR RESH | 012423109 | COMMON STOCK | 598,200 | $9,739,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 100,000 | $7,038,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 100,000 | $5,751,000 | thousands by filing date | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 77,208 | $5,178,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 150,000 | $4,673,000 | thousands by filing date | |
| PROSHARES TR | 74348A319 | ULTSHT RUSS2000 | 100,000 | $3,959,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 50,000 | $2,661,000 | thousands by filing date | |
| ARTIVION INC | 228903100 | COM | 200,000 | $2,266,000 | thousands by filing date | |
| ALBANY MOLECULAR RESH | 012423109 | COMMON STOCK | 120,000 | $1,954,000 | thousands by filing date | call |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 180,479 | $1,817,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 350,000 | $1,404,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 150,000 | $1,031,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 40,000 | $940,000 | thousands by filing date | call |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 400,000 | $908,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 100,000 | $801,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 100,000 | $687,000 | thousands by filing date | call |
| QLT INC | 746927102 | COMMON STOCK | 150,000 | $602,000 | thousands by filing date | call |
| ALIMERA SCIENCES INC | 016259103 | COM | 100,000 | $554,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 200,000 | $510,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 500,000 | $490,000 | thousands by filing date | call |
| FIBROCELL SCIENCE INC | 315721209 | COM NEW | 157,769 | $409,000 | thousands by filing date | |
| POZEN INC | 73941U102 | COMMON STOCK | 50,000 | $400,000 | thousands by filing date | call |
| STEMLINE THERAPEUTICS INC | 85858C107 | COM | 16,464 | $281,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 50,000 | $277,000 | thousands by filing date | call |
| CELSION CORPORATION COM PAR | 15117N404 | Stock | 100,000 | $233,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 50,000 | $149,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-15-001370 | this filing | 2015-02-13 | acceptance time not in the bulk data set |